TY - JOUR
T1 - Prebiotics in the management of pediatric gastrointestinal disorders
T2 - Position paper of the ESPGHAN special interest group on gut microbiota and modifications
AU - Indrio, Flavia
AU - Dinleyici, Ener Cagri
AU - Berni Canani, Roberto
AU - Domellöf, Magnus
AU - Francavilla, Ruggiero
AU - Guarino, Alfredo
AU - Gutierrez Castrellon, Pedro
AU - Orel, Rok
AU - Salvatore, Silvia
AU - Van den Akker, Chris H.P.
AU - Weizman, Zvi
N1 - Publisher Copyright:
© 2024 European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
PY - 2024/3/1
Y1 - 2024/3/1
N2 - Prebiotics are substrates that are selectively utilized by host microorganisms conferring a health benefit. Compared to probiotics there are few studies with prebiotics in children. Most studies have been performed using infant formula supplemented with prebiotics, while add-on prebiotic supplementation as prevention or treatment of childhood gastrointestinal disorders has rarely been reported. The aim of this position paper was to summarize evidence and make recommendations for prebiotic supplementation in children with gastrointestinal diseases. Recommendations made are based on publications up to January 1, 2023. Within the scope of the European Society for Paediatric Gastroenterology Hepatology and Nutrition Special Interest Group on Gut Microbiota and Modifications, as in our previous biotic recommendations, at least two randomized controlled clinical trials were required for recommendation. There are some studies showing benefits of prebiotics on selected outcomes; however, we cannot give any positive recommendations for supplementing prebiotics in children with gastrointestinal disorders.
AB - Prebiotics are substrates that are selectively utilized by host microorganisms conferring a health benefit. Compared to probiotics there are few studies with prebiotics in children. Most studies have been performed using infant formula supplemented with prebiotics, while add-on prebiotic supplementation as prevention or treatment of childhood gastrointestinal disorders has rarely been reported. The aim of this position paper was to summarize evidence and make recommendations for prebiotic supplementation in children with gastrointestinal diseases. Recommendations made are based on publications up to January 1, 2023. Within the scope of the European Society for Paediatric Gastroenterology Hepatology and Nutrition Special Interest Group on Gut Microbiota and Modifications, as in our previous biotic recommendations, at least two randomized controlled clinical trials were required for recommendation. There are some studies showing benefits of prebiotics on selected outcomes; however, we cannot give any positive recommendations for supplementing prebiotics in children with gastrointestinal disorders.
KW - children
KW - gastrointestinal disease
KW - infant
KW - oligosaccharides
UR - http://www.scopus.com/inward/record.url?scp=85188281403&partnerID=8YFLogxK
U2 - 10.1002/jpn3.12134
DO - 10.1002/jpn3.12134
M3 - Article
C2 - 38270255
AN - SCOPUS:85188281403
SN - 0277-2116
VL - 78
SP - 728
EP - 742
JO - Journal of Pediatric Gastroenterology and Nutrition
JF - Journal of Pediatric Gastroenterology and Nutrition
IS - 3
ER -